Acrivon Therapeutics, Inc. (ACRV)
NASDAQ: ACRV · IEX Real-Time Price · USD
12.50
-0.35 (-2.72%)
At close:
Dec 1, 2022 4:00 PM
12.70
+0.20 (1.60%)
After-hours:
Dec 1, 2022 6:25 PM EST
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2021 | 2020 |
|---|---|---|
| Selling, General & Admin
|
2.47 | 1.3 |
| Research & Development
|
13.72 | 1.87 |
| Operating Expenses
|
16.18 | 3.17 |
| Operating Income
|
-16.18 | -3.17 |
| Other Expense / Income
|
0.06 | 2.14 |
| Pretax Income
|
-16.24 | -5.31 |
| Net Income
|
-16.24 | -5.31 |
| Net Income Common
|
-16.24 | -5.31 |
| Shares Outstanding (Basic)
|
4 | 4 |
| Shares Outstanding (Diluted)
|
4 | 4 |
| Shares Change
|
21.70% | - |
| EPS (Basic)
|
-3.78 | -1.50 |
| EPS (Diluted)
|
-3.78 | -1.50 |
| Free Cash Flow Per Share
|
-3.31 | -0.80 |
| EBITDA
|
-15.41 | -5.29 |
| Depreciation & Amortization
|
0.83 | 0.01 |
| EBIT
|
-16.24 | -5.31 |
Source: Financials are provided by
Nasdaq Data Link
and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).